Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionQuantinno Capital Management LP
Latest Disclosed Ownership661,397 shares
Latest Disclosed Value $ 92,178,901
Quantinno Capital Management LP reports 21.61% increase in ownership of GILD / Gilead Sciences, Inc.

On May 15, 2026 - Quantinno Capital Management LP filed a 13F-HR form disclosing ownership of 661,397 shares of Gilead Sciences, Inc. (CH:GILD) valued at $92,178,901 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 543,863 shares of Gilead Sciences, Inc.. This represents a change in shares of 21.61% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 661,397 117,534 21.61 92,179 38.09 0.1538
2026-02-17 2025-12-31 13F GILEAD SCIENCES COM 375558103 543,863 151,329 38.55 66,754 53.21 0.1341
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 392,534 122,515 45.37 43,571 45.54 0.1189
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 270,019 87,191 47.69 29,937 46.14 0.1293
2025-05-12 2025-03-31 13F GILEAD SCIENCES COM 375558103 182,828 42,903 30.66 20,486 58.50 0.1334
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 139,925 58,305 71.43 12,925 88.86 0.1271
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 81,620 48,910 149.53 6,843 204.95 0.0890
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 32,710 -34,121 -51.06 2,244 -54.16 0.0404
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM 375558103 66,831 28,999 76.65 4,895 59.71 0.1064
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 37,832 5,197 15.92 3,065 25.31 0.1073
2023-11-14 2023-09-30 13F GILEAD SCIENCES COM 375558103 32,635 -10,714 -24.72 2,446 -26.79 0.1113
2023-08-04 2023-06-30 13F GILEAD SCIENCES COM 375558103 43,349 10,949 33.79 3,341 24.29 0.1908
2023-05-03 2023-03-31 13F GILEAD SCIENCES COM 375558103 32,400 5,039 18.42 2,688 14.43 0.1778
2023-02-13 2022-12-31 13F GILEAD SCIENCES COM 375558103 27,361 10,330 60.65 2,349 123.50 0.1752
2022-11-08 2022-09-30 13F GILEAD SCIENCES COM 375558103 17,031 9,155 116.24 1,051 115.81 0.1353
2022-08-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 7,876 7,876 487 0.0703
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.